Prosomnus Inc (OSA)

$0.47

Market is closed - opens 7 PM, 21 May 2024

Highlights

Market Capitalization
8.2M
Book Value
- $2.19
Earnings Per Share (EPS)
-1.49
Wall Street Target Price
2.5
Profit Margin
-87.14%
Operating Margin TTM
-63.92%
Return On Assets TTM
-40.15%
Return On Equity TTM
0.0%
Revenue TTM
27.7M
Revenue Per Share TTM
1.71
Quarterly Revenue Growth YOY
35.3%
Gross Profit TTM
7.3M
EBITDA
-17.2M
Diluted Eps TTM
-1.49
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-1.41
EPS Estimate Next Year
-1.1
EPS Estimate Current Quarter
-0.31
EPS Estimate Next Quarter
-0.33

Analyst Recommendation

Buy
    83%Buy
    16%Hold
    0
    0%Sell
Based on 6 Wall street analysts offering stock ratings for Prosomnus Inc(by analysts ranked 0 to 5 stars)
Based on 6 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
5
5
5
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 431.91%

Current $0.47
Target $2.50

Company Financials

FY20Y/Y Change
Revenue
8.3M
-
Net Income
-6.2M
-
Net Profit Margin
-74.5%
-
FY21Y/Y Change
Revenue
14.1M
↑ 69.86%
Net Income
-6.0M
↓ 3.17%
Net Profit Margin
-42.47%
↑ 32.03%
FY22Y/Y Change
Revenue
19.4M
↑ 37.79%
Net Income
3.3M
↓ 155.29%
Net Profit Margin
17.04%
↑ 59.51%
FY23Y/Y Change
Revenue
27.7M
↑ 42.59%
Net Income
-24.1M
↓ 829.12%
Net Profit Margin
-87.14%
↓ 104.18%
Q3 FY22Q/Q Change
Revenue
5.0M
↑ 2.84%
Net Income
-3.1M
↑ 10.61%
Net Profit Margin
-62.49%
↓ 4.39%
Q4 FY22Q/Q Change
Revenue
5.8M
↑ 15.89%
Net Income
2.2M
↓ 170.7%
Net Profit Margin
38.12%
↑ 100.61%
Q1 FY23Q/Q Change
Revenue
5.8M
↑ 0.28%
Net Income
-8.5M
↓ 483.52%
Net Profit Margin
-145.79%
↓ 183.91%
Q2 FY23Q/Q Change
Revenue
6.9M
↑ 19.38%
Net Income
904.9K
↓ 110.69%
Net Profit Margin
13.05%
↑ 158.84%
Q3 FY23Q/Q Change
Revenue
7.1M
↑ 1.98%
Net Income
-11.2M
↓ 1341.95%
Net Profit Margin
-158.93%
↓ 171.98%
Q4 FY23Q/Q Change
Revenue
7.8M
↑ 10.84%
Net Income
-6.9M
↓ 38.88%
Net Profit Margin
-87.63%
↑ 71.3%
FY20Y/Y Change
Total Assets
6.4M
-
Total Liabilities
53.6M
-
FY21Y/Y Change
Total Assets
7.6M
↑ 20.12%
Total Liabilities
60.9M
↑ 13.53%
FY22Y/Y Change
Total Assets
33.2M
↑ 334.63%
Total Liabilities
53.7M
↓ 11.78%
FY23Y/Y Change
Total Assets
26.3M
↓ 20.81%
Total Liabilities
52.9M
↓ 1.5%
Q3 FY22Q/Q Change
Total Assets
12.3M
↑ 13.13%
Total Liabilities
74.8M
↑ 7.11%
Q4 FY22Q/Q Change
Total Assets
33.2M
↑ 170.88%
Total Liabilities
53.7M
↓ 28.24%
Q1 FY23Q/Q Change
Total Assets
28.6M
↓ 13.89%
Total Liabilities
55.7M
↑ 3.83%
Q2 FY23Q/Q Change
Total Assets
25.2M
↓ 11.76%
Total Liabilities
51.0M
↓ 8.56%
Q3 FY23Q/Q Change
Total Assets
30.4M
↑ 20.45%
Total Liabilities
63.8M
↑ 25.07%
Q4 FY23Q/Q Change
Total Assets
26.3M
↓ 13.48%
Total Liabilities
52.9M
↓ 17.04%
FY20Y/Y Change
Operating Cash Flow
-3.8M
-
Investing Cash Flow
-85.4K
-
Financing Cash Flow
4.5M
-
FY21Y/Y Change
Operating Cash Flow
-4.6M
↑ 22.47%
Investing Cash Flow
-301.3K
↑ 252.64%
Financing Cash Flow
4.9M
↑ 9.51%
FY22Y/Y Change
Operating Cash Flow
-10.2M
↑ 120.91%
Investing Cash Flow
-1.4M
↑ 349.27%
Financing Cash Flow
26.0M
↑ 432.82%
Q3 FY22Q/Q Change
Operating Cash Flow
-1.5M
↓ 19.14%
Investing Cash Flow
-99.0K
-
Financing Cash Flow
2.6M
↑ 79.9%
Q4 FY22Q/Q Change
Operating Cash Flow
-5.5M
↑ 271.24%
Investing Cash Flow
-1.0M
↑ 932.17%
Financing Cash Flow
20.3M
↑ 688.59%
Q1 FY23Q/Q Change
Operating Cash Flow
-3.1M
↓ 43.54%
Investing Cash Flow
-974.6K
↓ 4.66%
Financing Cash Flow
-288.9K
↓ 101.43%
Q2 FY23Q/Q Change
Operating Cash Flow
-4.7M
↑ 51.88%
Investing Cash Flow
-237.2K
↓ 75.67%
Financing Cash Flow
-450.8K
↑ 56.06%

Technicals Summary

Sell

Neutral

Buy

Prosomnus Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin

Company Information

Organization
Prosomnus Inc
Employees
136
CEO
Mr. Leonard Liptak
Industry
Miscellaneous

FAQs